207 related articles for article (PubMed ID: 16551671)
1. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
Hellewell JS
J Psychopharmacol; 2006 Mar; 20(2 Suppl):39-45. PubMed ID: 16551671
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine - relapse prevention following mania.
Dando S; Tohen M
J Psychopharmacol; 2006 Mar; 20(2 Suppl):31-8. PubMed ID: 16551670
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the efficacy of treatments for bipolar depression.
Nierenberg AA
J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for bipolar disorder.
Yatham LN
Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
[TBL] [Abstract][Full Text] [Related]
5. Clinical decision making in the treatment of mania.
Perlis RH
J Clin Psychiatry; 2008; 69 Suppl 5():16-21. PubMed ID: 19265636
[TBL] [Abstract][Full Text] [Related]
6. The role of divalproex plus olanzapine in outpatient mixed-episode bipolar I disorder.
Goldberg JF
J Clin Psychiatry; 2009 Nov; 70(11):1548-50. PubMed ID: 20031096
[No Abstract] [Full Text] [Related]
7. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
8. Evolving trends in the long-term treatment of bipolar disorder.
Vieta E; Rosa AR
World J Biol Psychiatry; 2007; 8(1):4-11. PubMed ID: 17366344
[TBL] [Abstract][Full Text] [Related]
9. Use of antipsychotic drugs and lithium in mania.
Cookson J
Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics: newer options for mania and maintenance therapy.
Vieta E; Goikolea JM
Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of atypical antipsychotics in bipolar disorders.
Hirschfeld RM
J Clin Psychiatry; 2003; 64 Suppl 8():15-21. PubMed ID: 12892537
[TBL] [Abstract][Full Text] [Related]
12. A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E; Montes JM
Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
[TBL] [Abstract][Full Text] [Related]
13. The expanding pharmacopoeia for bipolar disorder.
Mitchell PB; Malhi GS
Annu Rev Med; 2002; 53():173-88. PubMed ID: 11818469
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects.
Srivastava S; Ketter TA
Clin Ther; 2011 Dec; 33(12):B40-8. PubMed ID: 22177379
[TBL] [Abstract][Full Text] [Related]
15. Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence?
Bowden C; Boyer P
Eur Psychiatry; 2003 Dec; 18 Suppl 1():19s-24s. PubMed ID: 23573637
[No Abstract] [Full Text] [Related]
16. The role of novel antipsychotics in bipolar disorders.
Yatham LN
J Clin Psychiatry; 2002; 63 Suppl 3():10-4. PubMed ID: 11908916
[TBL] [Abstract][Full Text] [Related]
17. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
Thase ME
J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
[TBL] [Abstract][Full Text] [Related]
18. [Olanzapine in the treatment of bipolar disorder].
Krüger S
Psychiatr Prax; 2006 Mar; 33 Suppl 1():S18-26. PubMed ID: 16511727
[TBL] [Abstract][Full Text] [Related]
19. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
[TBL] [Abstract][Full Text] [Related]
20. [Bipolar disorders: update on current treatment options].
de Souza DS; Riedel M; Möller HJ; Severus E
MMW Fortschr Med; 2010 Mar; 152(9):50-2. PubMed ID: 20384098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
